FDA Eases Way For Gold-Standard Biosimilars
The U.S. Food and Drug Administration on Friday cemented its criteria for approving cream-of-the-crop biosimilars that pharmacies can automatically substitute in place of pricier biologics, simplifying standards it previously proposed and handing...To view the full article, register now.
Already a subscriber? Click here to view full article